Balance disorders are common and may significantly impact upon quality of life and independence. Impaired balance may result in falls with resulting morbidity and mortality, particularly in older people.
- Home
- Search
- Tools
- CME
- Help & Feedback
- About epocrates
- Business Solutions
ProfileSign in
Summary
Epidemiology
Estimates of dizziness and vertigo in the community range from 17% to 30% and from 3% to 10%, respectively.[1] The prevalence of balance problems at age 70 years is reported to be 36% in women and 29% in men.[2]
Symptoms of dizziness or vertigo may constitute between 1% and 15.5% of primary care consultations.[3] Among the most commonly reported etiologies in primary care are vestibular/peripheral (5.4% to 42.1%), benign paroxysmal positional vertigo (4.3% to 39.5%), cardiovascular disease (3.8% to 56.8%), psychogenic (1.8% to 21.6%), Menière disease (1.4% to 2.7%), neurologic disease (1.4% to 11.4%) vestibular neuritis (0.6% to 24%), and no clear diagnosis (up to 80.2%).[3]
Last updated
Citations
Goebel JA. 2015 Equilibrium Committee Amendment to the 1995 AAO-HNS Guidelines for the Definition of Ménière's Disease. Otolaryngol Head Neck Surg. 2016 Mar;154(3):403-4.[Abstract]
Expert Panel on Neurologic Imaging:, Sharma A, Kirsch CFE, et al. ACR Appropriateness Criteria(®) Hearing Loss and/or Vertigo. J Am Coll Radiol. 2018 Nov;15(11s):S321-S331.[Abstract][Full Text]
Expert Panel on Neurologic Imaging:, Salmela MB, Mortazavi S, et al. ACR Appropriateness Criteria(®) Cerebrovascular Disease. J Am Coll Radiol. 2017 May;14(5s):S34-S61.[Abstract][Full Text]
Bhattacharyya N, Gubbels SP, Schwartz SR, et al. Clinical Practice Guideline: Benign Paroxysmal Positional Vertigo (Update). Otolaryngol Head Neck Surg. 2017 Mar;156(3_suppl):S1-S47.[Abstract]
1. Murdin L, Schilder AG. Epidemiology of balance symptoms and disorders in the community: a systematic review. Otol Neurotol. 2015 Mar;36(3):387-92.[Abstract]
2. Jonsson R, Sixt E, Landahl S, et al. Prevalence of dizziness and vertigo in an urban elderly population. J Vestib Res. 2004;14(1):47-52.[Abstract]
3. Bösner S, Schwarm S, Grevenrath P, et al. Prevalence, aetiologies and prognosis of the symptom dizziness in primary care - a systematic review. BMC Fam Pract. 2018 Feb 20;19(1):33.[Abstract][Full Text]
4. Baloh RW, Jacobson K, Winder T. Drop attacks with Meniere's syndrome. Ann Neurol. 1990 Sep;28(3):384-7.[Abstract]
5. Goebel JA. 2015 Equilibrium Committee Amendment to the 1995 AAO-HNS Guidelines for the Definition of Ménière's Disease. Otolaryngol Head Neck Surg. 2016 Mar;154(3):403-4.[Abstract]
6. Brantberg K, Ishiyama A, Baloh RW. Drop attacks secondary to superior canal dehiscence syndrome. Neurology. 2005 Jun 28;64(12):2126-8.[Abstract]
7. Sowula K, Składzień J, Szaleniec J, et al. Otolaryngological symptoms in patients treated for tick-borne diseases. Otolaryngol Pol. 2018 Feb 28;72(1):30-34.[Abstract][Full Text]
8. Buniel MC, Geelan-Hansen K, Weber PC, et al. Immunosuppressive therapy for autoimmune inner ear disease. Immunotherapy. 2009 May;1(3):425-34.[Abstract][Full Text]
9. Pothier DD, Rutka JA, Ranalli PJ. Double impairment: clinical identification of 33 cases of cerebellar ataxia with bilateral vestibulopathy. Otolaryngol Head Neck Surg. 2012 May;146(5):804-8.[Abstract]
10. Brantberg K, Trees N, Baloh RW. Migraine-associated vertigo. Acta Otolaryngol. 2005 Mar;125(3):276-9.[Abstract]
11. Hain TC, Hanna PA, Rheinberger MA. Mal de debarquement. Arch Otolaryngol Head Neck Surg. 1999 Jun;125(6):615-20.[Abstract]
12. Sirven JI, Fife TD, Wingerchuk DM, et al. Second-generation antiepileptic drugs' impact on balance: a meta-analysis. Mayo Clin Proc. 2007 Jan;82(1):40-7.[Abstract]
13. Kattah JC, Talkad AV, Wang DZ, et al. HINTS to diagnose stroke in the acute vestibular syndrome: three-step bedside oculomotor examination more sensitive than early MRI diffusion-weighted imaging. Stroke. 2009 Nov;40(11):3504-10.[Abstract][Full Text]
14. Furman JM, Becker JT. Vestibular responses in Wernicke's encephalopathy. Ann Neurol. 1989 Nov;26(5):669-74.[Abstract]
15. Newman-Toker DE, Dy FJ, Stanton VA, et al. How often is dizziness from primary cardiovascular disease true vertigo? A systematic review. J Gen Intern Med. 2008 Dec;23(12):2087-94.[Abstract][Full Text]
16. Lee H, Baloh RW. Sudden deafness in vertebrobasilar ischemia: clinical features, vascular topographical patterns and long-term outcome. J Neurol Sci. 2005 Jan 15;228(1):99-104.[Abstract]
17. Asawavichiangianda S, Fujimoto M, Mai M, et al. Significance of head-shaking nystagmus in the evaluation of the dizzy patient. Acta Otolaryngol Suppl. 1999;540:27-33.[Abstract]
18. Weber KP, Aw ST, Todd MJ, et al. Head impulse test in unilateral vestibular loss: vestibulo-ocular reflex and catch-up saccades. Neurology. 2008 Feb 5;70(6):454-63.[Abstract]
19. Expert Panel on Neurologic Imaging:, Sharma A, Kirsch CFE, et al. ACR Appropriateness Criteria(®) Hearing Loss and/or Vertigo. J Am Coll Radiol. 2018 Nov;15(11s):S321-S331.[Abstract][Full Text]
20. Expert Panel on Neurologic Imaging:, Salmela MB, Mortazavi S, et al. ACR Appropriateness Criteria(®) Cerebrovascular Disease. J Am Coll Radiol. 2017 May;14(5s):S34-S61.[Abstract][Full Text]
21. Saber Tehrani AS, Kattah JC, Mantokoudis G, et al. Small strokes causing severe vertigo: frequency of false-negative MRIs and nonlacunar mechanisms. Neurology. 2014 Jul 8;83(2):169-73.[Abstract]
22. Timmer FC, Zhou G, Guinan JJ, et al. Vestibular evoked myogenic potential (VEMP) in patients with Meniere's disease with drop attacks. Laryngoscope. 2006 May;116(5):776-9.[Abstract]
23. Leigh D, McBurney A, McIlwain H. Erythrocyte transketolase activity in the Wernicke-Korsakoff syndrome. Br J Psychiatry. 1981 Aug;139:153-6.[Abstract]
24. Bhattacharyya N, Gubbels SP, Schwartz SR, et al. Clinical Practice Guideline: Benign Paroxysmal Positional Vertigo (Update). Otolaryngol Head Neck Surg. 2017 Mar;156(3_suppl):S1-S47.[Abstract]
25. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018 Jan;38(1):1-211.[Abstract][Full Text]
26. Polensek SH, Tusa RJ. Nystagmus during attacks of vestibular migraine: an aid in diagnosis. Audiol Neurootol. 2010;15(4):241-6.[Abstract]
27. Welgampola MS, Myrie OA, Minor LB, et al. Vestibular-evoked myogenic potential thresholds normalize on plugging superior canal dehiscence. Neurology. 2008 Feb 5;70(6):464-72.[Abstract]
28. Curtin HD. Superior semicircular canal dehiscence syndrome and multi-detector ROW CT. Radiology. 2003 Feb;226(2):312-4.[Abstract]
29. Manto MU. The wide spectrum of spinocerebellar ataxias (SCAs). Cerebellum. 2005;4(1):2-6.[Abstract]
30. Baloh RW. Paraneoplastic cerebellar disorders. Otolaryngol Head Neck Surg. 1995 Jan;112(1):125-7.[Abstract]
31. Harding AE, Matthews S, Jones S, et al. Spinocerebellar degeneration associated with a selective defect of vitamin E absorption. N Engl J Med. 1985 Jul 4;313(1):32-5.[Abstract]
32. Hopper AD, Hadjivassiliou M, Hurlstone DP, et al. What is the role of serologic testing in celiac disease? A prospective, biopsy-confirmed study with economic analysis. Clin Gastroenterol Hepatol. 2008 Mar;6(3):314-20.[Abstract]
33. Elble RJ, Cousins R, Leffler K, et al. Gait initiation by patients with lower-half parkinsonism. Brain. 1996 Oct;119 (Pt 5):1705-16.[Abstract]
34. Curran T, Lang AE. Parkinsonian syndromes associated with hydrocephalus: case reports, a review of the literature, and pathophysiological hypotheses. Mov Disord. 1994 Sep;9(5):508-20.[Abstract]
35. Polyzoidis KS, McQueen JD, Rajput AH, et al. Parkinsonism as a manifestation of brain tumor. Surg Neurol. 1985 Jan;23(1):59-63.[Abstract]
36. Hageman AT, Horstink MW. Parkinsonism due to a subdural hematoma. Mov Disord. 1994 Jan;9(1):107-8.[Abstract]
37. Kato N, Arai K, Hattori T. Study of the rostral midbrain atrophy in progressive supranuclear palsy. Neurol Sci. 2003 Jun 15;210(1-2):57-60.[Abstract]
38. Oba H, Yagishita A, Terada H, et al. New and reliable MRI diagnosis for progressive supranuclear palsy. Neurology. 2005 Jun 28;64(12):2050-5.[Abstract]
39. Fross RD, Daube JR. Neuropathy in the Miller Fisher syndrome: clinical and electrophysiologic findings. Neurology. 1987 Sep;37(9):1493-8.[Abstract]
40. Willison HJ, Veitch J, Paterson G, et al. Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside. J Neurol Neurosurg Psychiatry. 1993 Feb;56(2):204-6.[Abstract][Full Text]
41. Chiba A, Kusunoki S, Obata H, et al. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barre syndrome: clinical and immunohistochemical studies. Neurology. 1993 Oct;43(10):1911-7.[Abstract]
42. Ropper AH, Wijdicks EFM, Truax BT. Guillain-Barre syndrome. Philadelphia, PA: F.A. Davis; 1991.
43. Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006 May 23;66(10):1485-9.[Abstract]
44. Lennon VA, Kryzer TJ, Pittock SJ, et al. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med. 2005 Aug 15;202(4):473-7.[Abstract][Full Text]
45. Lindenbaum J, Savage DG, Stabler SP, et al. Diagnosis of cobalamin deficiency: II. Relative sensitivities of serum cobalamin, methylmalonic acid, and total homocysteine concentrations. Am J Hematol. 1990 Jun;34(2):99-107.[Abstract]
46. Hart G. Syphilis tests in diagnostic and therapeutic decision making. Ann Intern Med. 1986 Mar;104(3):368-76.[Abstract]
47. Marra CM, Tantalo LC, Maxwell CL, et al. Alternative cerebrospinal fluid tests to diagnose neurosyphilis in HIV-infected individuals. Neurology. 2004 Jul 13;63(1):85-8.[Abstract]
48. Lewinsohn DM, Leonard MK, LoBue PA, et al. Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention clinical practice guidelines: diagnosis of tuberculosis in adults and children. Clin Infect Dis. 2017 Jan 15;64(2):e1-33.[Abstract]
49. Geldmacher H, Taube C, Kroeger C, et al. Assessment of lymph node tuberculosis in northern Germany: a clinical review. Chest. 2002 Apr;121(4):1177-82.[Abstract][Full Text]
50. Weir MR, Thornton GF. Extrapulmonary tuberculosis. Experience of a community hospital and review of the literature. Am J Med. 1985 Oct;79(4):467-78.[Abstract]
51. Baydur A. The spectrum of extrapulmonary tuberculosis. West J Med. 1977 Apr;126(4):253-62.[Abstract]
52. Nataraj G, Kurup S, Pandit A, et al. Correlation of fine needle aspiration cytology, smear and culture in tuberculous lymphadenitis: a prospective study. J Postgrad Med. 2002;48(2):113-6.[Abstract]
53. World Health Organization. WHO consolidated guidelines on tuberculosis: module 3: diagnosis: rapid diagnostics for tuberculosis detection. Mar 2024 [internet publication].[Full Text]
54. Lewinsohn DM, Leonard MK, LoBue PA, et al. Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: diagnosis of tuberculosis in adults and children. Clin Infect Dis. 2017;64(2):111-5.[Abstract]
55. Bjerrum S, Schiller I, Dendukuri N, et al. Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in people living with HIV. Cochrane Database Syst Rev. 2019 Oct 21;10(10):CD011420.[Abstract][Full Text]
56. Puccioni-Sohler M, Rios M, Carvalho SM, et al. Diagnosis of HAM/TSP based on CSF proviral HTLV-I DNA and HTLV-I antibody index. Neurology. 2001 Aug 28;57(4):725-7.[Abstract]
